In this study, all patients will get investigational drug. There will be no comparator drug.
This study will evaluate three tumor types: T-cell lymphoma, Indolent B-cell lymphoma, and
Aggressive B-cell lymphoma. Each tumor type will include several tumor subtypes:
- T-cell lymphoma: Peripheral and Cutaneous T-cell lymphoma (PTCL, CTCL)
- Indolent B-cell lymphoma: Small lymphocytic lymphoma, follicular lymphoma (Gr 1 or 2)
and marginal zone lymphoma
- Aggressive B-cell lymphoma: Primary CNS lymphoma, follicular lymphoma (Gr 3a and 3b) and
aggressive lymphoma with prior clinical history of indolent lymphoma.